Clinical Study
Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L
Full Title
A Single-center, Open-label, Ascending Nicotine Levels Study to Investigate the Nicotine Pharmacokinetic and Pharmacodynamics Profiles, Safety and Tolerability of P3L in Smoking Healthy Subjects in Relation to NicoretteĀ® Inhalator
Authored by
PMI
Abstract
The purpose of this study is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD, i.e., subjective effects) profiles, and the safety and tolerability of the nicotine-containing aerosol delivered by Platform 3 Liquid (P3L) system at three different nicotine levels in smoking healthy subjects in Relation to NicoretteĀ®.
Summary
Recruitment | Completed |
Study Results | No Results Available |
Enrollment | 16 |
Study Type | Interventional |
Other IDs | P3L-PK-01-NZ |
-
Published On
March 3, 2017 -
Full publication
-
Identifier
NCT02532374